The Latest Biology News And Medical NewsBiology News 2Health News 2Biology News 3Health News 3
HOME >> MEDICINE >> NEWS
New data on Orqis Medical's Cancion CRS to be reported at ACC

Lake Forest, Calif. March 7, 2005 Newly analyzed research on Orqis Medical's Cancion CRSTM cardiac recovery system for treating congestive heart failure will be presented at the Annual Scientific Session of the American College of Cardiology (ACC), held in Orlando, Florida (March 6-9).

The data suggests that patients with acutely decompensated chronic heart failure may benefit from the first-of-its-kind Cancion therapy. Based on Orqis Medical's proprietary discoveries in hemodynamic principles, the therapy is designed to create a unique "rest to recovery" environment that enables the failing heart to rest as it continues to function. It represents a significant departure from conventional drug therapy and more invasive blood pumps, which either force the failing heart to work harder, or rest it to the point where it begins to atrophy.

"The patients we analyzed clearly benefited from the Cancion CRS therapy," said Michael Zile, M.D., who analyzed the research data. "By providing continuous aortic flow augmentation, the therapy enabled patients to experience progressive improvement in key measures such as cardiac index and pulmonary capillary wedge pressure."

Dr. Zile's oral presentation (AAC 864-8) is titled "Continuous Aortic Flow Augmentation Using Orqis Cancion Cardiac Recovery System in Patients with Severe Heart Failure: Determinants of the Hemodynamic Response." It will be delivered by Dr. Zile on Wednesday, March 9th at 9:45 a.m. The presentation includes data from 24 patients with congestive heart failure who participated in Orqis Medical's feasibility trials in the US and Europe.


'"/>

Contact: Erik Deutsch
erikd@excelpr.com
323-851-2455
Orqis Medical
7-Mar-2005


Page: 1

Related medicine news :

1. Orqis receives FDA approval to expand clinical trial of Cancion CRS therapy to 40 centers
2. First UK cases of previously rare disease reported in gay men
3. Decline in cardiovascular disease reported in patients with diabetes
4. Latest Asian-American tobacco use data reported
5. Study says widely reported side effect of chemotherapy may be overestimated
6. Prevalence of chronic sinusitis may be lower than commonly reported
7. Study finds vertebral fractures are underreported
8. First reported cases of North Asian tick typhus among North Americans
9. Differences in cancer screening rates reported
10. University of Pittsburgh intestine transplant results reported at international meeting
11. 1st successful national CQI intervention in medicine reported

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: New data Orqis Medical Cancion CRS reported ACC

(Date:11/23/2009)... What could have been a simple case for a N... turns into a murder charge. , ...ould have been a case for New York auto accident ...an incident of road rage turned fatal., , , , ,Ac...a Brooklyn driver was shot and killed during a hea...
(Date:11/23/2009)...eivesAccreditationforFivePopulationHealthPrograms ...--ThePopulationHealthImpactInstitute(PHII),anon-pr...PHII,sBoardofDirectorshasapprovedtheHealthcareTran...woyearsofdevelopment.Nurtur(TM),alife,health,andwe...ationtoreceivetheH-TAPaccreditationsealforfiveofit...
(Date:11/23/2009)...,Nov.23/PRNewswire/--Thanksgivingweekendmarksthe36...dition,theClassicrepresentsthesportsmanshipandprid...fNewOrleansandthoseinattendance. ,, Forthecrewo...ceforsomedowntimebeforetheyworktotestandlaunchabra...construction,PettyOfficerClaudeBovellandtherestoft...
(Date:11/23/2009)...cularly H1N1, has understandably captured the atte...e public. However, an analysis from Children,s Hos...ncy department (ED) during several recent flu seas...al virus (RSV) -- takes a substantially greater di... flu. , Although the data come from the pre-H1N1...
(Date:11/23/2009)...mo regimen may improve patient outcomes, research ...News) -- A new combination drug therapy shows prom...ct cancers, researchers say. , The study from t... Boston found that survival and tumor response in ...giogenesis inhibitor that has helped slow the grow...
Breaking Medicine News(10 mins):Health News:An Incident of Road Rage Turns Into Murder 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 2Health News:Population Health Impact Institute Launches Healthcare Transparency Accreditation Program(TM) 3Health News:Nothing Is Like Being There 2Health News:Amid the flu epidemic, don't forget RSV in young children 2Health News:Amid the flu epidemic, don't forget RSV in young children 3Health News:Combo Treatment Beneficial in Biliary-Tract Cancer Study 2
(Date:11/23/2009)...ewswire-FirstCall/--Oceanside Pharmaceuticals ,par... ),todayannouncedthatithasnowlaunchedchlordiazepox...neric(AG)versionofLibrax®.Oceansidehasreceive...heLibrax®genericmarket. ,, "Valeant,sOcean...esswithitssuccessfullaunchanddistributionof5%fluor...
(Date:11/23/2009)...ewswire-FirstCall/--NeurobiologicalTechnologies,In...ofdirectorshasdeclaredanextraordinarydividendof$0....,2009tostockholdersofrecordasofNovember30,2009.The...derapprovalofthedissolutionofNTIpursuanttoaplanofc...rdinarydividendof$0.75persharethatwaspaidtoshareho...
(Date:11/23/2009)...ire/--AdvancedSterilizationProducts(ASP),aleadingg...todaytheacquisitionbyitsFrenchaffiliate,ApsisS.A.S...ivedisinfectionprocessesandtechnologiestopreventhe...erenotdisclosed. ,, GlosterEuropedesignsandmark...ovidesdisinfectionofpatientenvironmentssuchashospi...
Breaking Medicine Technology:Oceanside Pharmaceuticals Announces Launch of Librax(R) AG 2Neurobiological Technologies Announces Extraordinary Dividend of $0.18 per Share 2ASP Announces Acquisition of Gloster Europe to Help Reduce Infections in Healthcare Facilities 2Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 1Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 2Employers Recognize Potential Impact of Employee Health Management on Future Plan Costs 53427 3John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 1John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 2John Legend and Gap Join 28PRODUCT 29RED 28TM 29 to Help Eliminate AIDS in Africa with Exclusive 28RED 29ZONE Seating at Madison Square Garden 4807 3Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 1Online H1N1 Management 3A FairChoice Helps Schools Respond to Infectious Disease on Campus 4806 2
Other News:
...ring from overactive bladder can significantly and...taking a once-a-day, extended-release formulation ...ng to a study conducted by the Cleveland Clinic Fo...nual Scientific Meeting of the American Geriatrics...
...ial and Extension Study Data Presented by Clevelan...cal Association Meeting..Clinical results from fam... with Aptosyn™(exisulind) for up to 18 months ...American Gastroenterological Association (AGA) by ...
...esearchers at the University of Pittsburgh Cancer ..., histamine dihydrochloride (Maxamine), used in co..., improved survival for stage-IV malignant melanom...me doses of IL-2 alone. The Phase III, multi-cent...
...5, 2000 -- Aventis Pharmaceuticals announced today...ts, twice daily (BID), are now available by prescr...s (SAR) and chronic idiopathic urticaria (CIU) in ...affect up to six million children in the United St...
health news:Overactive bladder episodes completely controlled in 40 percent of elderly patients treated with once-a-day Oxybutynin 2health news:Overactive bladder episodes completely controlled in 40 percent of elderly patients treated with once-a-day Oxybutynin 3health news:Cell Pathways' Aptosyn™ (exisulind) shows continuing long-term prevention of colon polyps in FAP patients 2health news:New 'combination therapy' improves survival for malignant melanoma patients 2health news:New 'combination therapy' improves survival for malignant melanoma patients 3health news:Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years 2health news:Aventis Pharmaceuticals Allegra (Fexofenadine Hcl) 30-Mg tablets now available to treat seasonal allergies, chronic hives in children 6 to 11 years 3
... for enhancing cognitive function provided relief ...ors who were coping with a side effect known as ch...Medical Center study.... Sixty-eight women, who ha...ted in an eight-week clinical trial testing the ef...
... the body's immune response, creating a concern th...vaccines being used against brain tumors. But a ne...isch Brain Tumor Center at Duke University and The...has found that the opposite is true: chemotherapy ...
... with cancer about the likely course of the diseas... is poor, according to a Dana-Farber Cancer Instit...he American Society of Clinical Oncology annual me...ious studies suggest that physicians are reluctant...
...lopment (R&D) facility providing services to the g... was officially launched today by Minister for Sta...s, John Mickel. ... The facility, which helps to m...arket more quickly, provides expertise and support...
health news:Brain-boosting pill alleviates post-chemotherapy fogginess 2health news:Chemotherapy may enhance the effectiveness of brain tumor vaccines 2health news:New drug development facility helps move medicines to market 2